Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Surprise! HSC Are Aberrant in Chronic Lymphocytic Leukemia CANCER CELL Alizadeh, A. A., Majeti, R. 2011; 20 (2): 135-136

Abstract

In this issue of Cancer Cell, Kikushige et al. report the surprising finding that, in human chronic lymphocytic leukemia (CLL), hematopoietic stem cells (HSC) aberrantly generate clonal B cells with CLL-like phenotypes, which implicate HSC in the pathogenesis of this mature lymphoid malignancy and has major implications for CLL therapies.

View details for DOI 10.1016/j.ccr.2011.08.001

View details for Web of Science ID 000294099700002

View details for PubMedID 21840478